EE200200410A - Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid - Google Patents

Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid

Info

Publication number
EE200200410A
EE200200410A EEP200200410A EEP200200410A EE200200410A EE 200200410 A EE200200410 A EE 200200410A EE P200200410 A EEP200200410 A EE P200200410A EE P200200410 A EEP200200410 A EE P200200410A EE 200200410 A EE200200410 A EE 200200410A
Authority
EE
Estonia
Prior art keywords
starting
preparation
intermediate compounds
compounds
Prior art date
Application number
EEP200200410A
Other languages
English (en)
Inventor
Breipohl Gerhard
Holla Wolfgang
Jendralla Heiner
Beck Gerhard
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200410A publication Critical patent/EE200200410A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200410A 2000-01-28 2001-01-18 Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid EE200200410A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10003586 2000-01-28
PCT/EP2001/000523 WO2001055175A2 (en) 2000-01-28 2001-01-18 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides

Publications (1)

Publication Number Publication Date
EE200200410A true EE200200410A (et) 2003-12-15

Family

ID=7628946

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200410A EE200200410A (et) 2000-01-28 2001-01-18 Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid

Country Status (30)

Country Link
US (2) US20010031858A1 (et)
EP (1) EP1254159B9 (et)
JP (1) JP4778181B2 (et)
KR (1) KR100758141B1 (et)
CN (1) CN1176104C (et)
AR (1) AR027246A1 (et)
AT (1) ATE325810T1 (et)
AU (1) AU779722B2 (et)
BR (1) BR0107804A (et)
CA (1) CA2398497C (et)
CZ (1) CZ20022583A3 (et)
DE (1) DE60119491T2 (et)
DK (1) DK1254159T3 (et)
EE (1) EE200200410A (et)
ES (1) ES2262632T3 (et)
HK (1) HK1051866A1 (et)
HR (1) HRP20020631A2 (et)
HU (1) HUP0301986A2 (et)
IL (2) IL150897A0 (et)
MX (1) MXPA02006762A (et)
NO (1) NO20023577L (et)
NZ (1) NZ520427A (et)
PL (1) PL356801A1 (et)
PT (1) PT1254159E (et)
RU (1) RU2250212C2 (et)
SK (1) SK10842002A3 (et)
TW (1) TWI236481B (et)
WO (1) WO2001055175A2 (et)
YU (1) YU51202A (et)
ZA (1) ZA200205990B (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695999A5 (de) 2002-02-28 2006-11-15 Wilex Ag Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten.
JP2009518345A (ja) * 2005-12-07 2009-05-07 テフニーシェ ウニヴェルジテート ミュンヘン 因子viiiおよび因子viii様タンパク質に対する小型ペプチドおよびペプチド模倣物の親和性リガンド
CN101774942B (zh) * 2010-01-27 2012-08-22 宁波武盛化学有限公司 制备n-乙酰基-dl-环己基甘氨酸的方法
CN102984945B (zh) * 2010-04-20 2014-08-20 凯瑞斯德生化(苏州)有限公司 一种环烯基在β位取代的丙氨酸的不对称合成方法
EP2646150A4 (en) * 2010-11-29 2014-10-08 Takasago Perfumery Co Ltd CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR PRODUCING AN OPTICALLY ACTIVE CARBONYL COMPOUND THEREWITH
CN115068469B (zh) * 2022-07-08 2024-02-27 深圳市小分子新药创新中心有限公司 Tigit抑制剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4440679A (en) 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
ZA953361B (en) * 1994-04-26 1996-01-12 Selectide Corp Factor Xa inhibitors
US5849510A (en) 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
RU2170764C2 (ru) * 1995-12-20 2001-07-20 Авентис Фармасьютикалз Инк. НОВЫЙ СПОСОБ ПОЛУЧЕНИЯ N-АЦЕТИЛ-(L)-4-ЦИАНОФЕНИЛАЛАНИНА АС-(L)-PHE(4-CN)-OH И N-АЦЕТИЛ-(L)-N-АМИДИНОФЕНИЛАЛАНИН-ЦИКЛОГЕКСИЛ-ГЛИЦИН-β-(3-N-МЕТИЛПИРИДИН ИЯ)-АЛАНИНА АС-(L)-PАPH-СHG-РAL МE(3)-NH2
DE19856443A1 (de) 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat

Also Published As

Publication number Publication date
EP1254159B9 (en) 2006-06-28
RU2250212C2 (ru) 2005-04-20
US20010031858A1 (en) 2001-10-18
CA2398497A1 (en) 2001-08-02
WO2001055175A2 (en) 2001-08-02
BR0107804A (pt) 2002-10-22
EP1254159B1 (en) 2006-05-10
US7084250B2 (en) 2006-08-01
US20040225109A1 (en) 2004-11-11
HUP0301986A2 (hu) 2003-09-29
TWI236481B (en) 2005-07-21
AU4051601A (en) 2001-08-07
YU51202A (sh) 2005-11-28
CN1396928A (zh) 2003-02-12
NO20023577L (no) 2002-08-28
HK1051866A1 (en) 2003-08-22
HRP20020631A2 (en) 2004-12-31
PT1254159E (pt) 2006-07-31
CA2398497C (en) 2011-04-26
JP2003523364A (ja) 2003-08-05
DK1254159T3 (da) 2006-09-11
CZ20022583A3 (cs) 2002-10-16
AU779722B2 (en) 2005-02-10
JP4778181B2 (ja) 2011-09-21
DE60119491T2 (de) 2006-11-16
ES2262632T3 (es) 2006-12-01
EP1254159A2 (en) 2002-11-06
NZ520427A (en) 2004-02-27
ZA200205990B (en) 2003-04-30
NO20023577D0 (no) 2002-07-26
RU2002123046A (ru) 2004-01-10
AR027246A1 (es) 2003-03-19
DE60119491D1 (de) 2006-06-14
IL150897A (en) 2008-08-07
KR100758141B1 (ko) 2007-09-13
CN1176104C (zh) 2004-11-17
KR20030019306A (ko) 2003-03-06
IL150897A0 (en) 2003-02-12
ATE325810T1 (de) 2006-06-15
WO2001055175A3 (en) 2002-02-21
PL356801A1 (en) 2004-07-12
MXPA02006762A (es) 2002-10-23
SK10842002A3 (sk) 2003-04-01

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EE05223B1 (et) Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
FI20011621A (fi) Menetelmä sitalopraamin valmistamiseksi
NO20023928L (no) Fremgangsmåte ved fremstillingen av citalopram
NO20024007L (no) Fremgangsmåte ved fremstillingen av citalopram
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
DE60121150D1 (de) Verfahren zur herstellung von ansamitocin
EE05308B1 (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20024180L (no) Fremgangsmåte ved fremstillingen av citalopram
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20024213L (no) FremgangsmÕte ved fremstilling av citalopram
AU8311901A (en) Polymorphs of zaleplon and methods for the preparation thereof
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
EE200200410A (et) Meetod atsetüülamidiniofenüülalanüültsükloheksüülglütsüülpüridinioalaniinamiidide valmistamiseks ning selleks vajalikud lähte- ja vaheühendid
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20031927L (no) Forbedret fremgangsmåte for fremstilling av gabapentinmellomprodukt
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
NO20024214D0 (no) Fremgangsmåte ved fremstilling av citalopram
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder